Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in:

31.05.2023 | case report

A rare Serratia marcescens-associated acute endocarditis of a tricuspid valve in an intravenous drug user

A case report and literature review

verfasst von: Tibor Poruban, Mikulas Hunavy, Daniel Farkas, Stanislav Carnoky, Marta Jakubova

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 21-22/2023

Einloggen, um Zugang zu erhalten

Summary

Serratia marcescens is a gram-negative bacillus that is an opportunistic agent in respiratory tract infections, urinary tract infections, and septicemia. It is rarely also a cause of infective endocarditis which follows a rapid and devastating course, typically in persons with history of intravenous drug use (IDU). This article reports a fatal case of a 27-year-old patient with a known history of IDU, who presented with clinical symptoms concerning right-sided endocarditis as well as signs of acute respiratory distress syndrome. Finally, a detailed review of the literature is provided concerning the acute endocarditis of a tricuspid valve, especially associated with Serratia marcescens infection.
Vorheriger Artikel Adult patients with tetanus in Slovenia 2006–2021
Nächster Artikel Crimean-Congo hemorrhagic fever in Iraq: Humanity before heroism
Literatur
1.
Hubers SA, DeSimone DC, Gersh BJ, Anavekar NS. Infective endocarditis: A contemporary review. Mayo Clin Proc. 2020;95(5):982–97.CrossRefPubMed
2.
Rudasill SE, Sanaiha Y, Mardock AL, et al. Clinical outcomes of infective endocarditis in injection drug users. j Am Coll Cardiol. 2019;73(5):559–70.CrossRefPubMed
3.
Cristina ML, Sartini M, Spagnolo AM. Serratia marcescens infections in Neonatal Intensive Care Units (NICUs). Int J Environ Res Public Health. 2019;16(4):610.CrossRefPubMedPubMedCentral
4.
Wheat RP, Zuckerman A, Rantz LA. Infection due to chromobacteria; report of 11 cases. AMA Arch Intern Med. 1951;88(4):461–6.CrossRefPubMed
5.
Hou J, Mao D, Zhang Y, et al. Long-term spatiotemporal variation of antimicrobial resistance genes within the Serratia marcescens population and transmission of S. marcescens revealed by public whole-genome datasets. J Hazard Mater. 2022;423(Pt B):127220.CrossRefPubMed
6.
Veve MP, McCurry ED, Cooksey GE, Shorman MA. Epidemiology and outcomes of non-HACEK infective endocarditis in the southeast United States. plos One. 2020;15(3):e230199.CrossRefPubMedPubMedCentral
7.
Luttmann K, Starnes VR, Haddad M, Duggan J. Serratia marcescens, a rare and devastating cause of endocarditis: A case report and review of the literature. Cureus. 2022;14(6):e25572.PubMedPubMedCentral
8.
Clarelin A, Rasmussen M, Olaison L, Ragnarsson S. Comparing right- and left sided injection-drug related infective endocarditis. Sci Rep. 2021;11(1):1177.CrossRefPubMedPubMedCentral
9.
Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis. 2000;30(2):374–9.CrossRefPubMed
10.
Libby P, Bonow RO, Mann DL, et al. Braunwald’s heart disease—A textbook of cardiovascular medicine. 12th ed. Amsterdam: Elsevier; 2021. p. 2034. ISBN 978-0-323-72219‑3.
11.
Cuervo G, Escrihuela-Vidal F, Gudiol C, Carratalà J. Current challenges in the management of infective Endocarditis. Front Med (lausanne). 2021;8:641243.CrossRefPubMed
12.
Rodger L, Shah M, Shojaei E, Hosseini S, Koivu S, Silverman M. Recurrent endocarditis in persons who inject drugs. Open Forum Infect Dis. 2019;6(10):ofz396.CrossRefPubMedPubMedCentral
13.
Luttmann K, Starnes VR, Haddad M, Duggan J. Serratia marcescens, a rare and devastating cause of Endocarditis: A case report and review of the literature. Cureus. 2022;14(6):e25572.PubMedPubMedCentral
14.
Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128.CrossRefPubMed
15.
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–86.CrossRefPubMed
16.
Sordelli C, Fele N, Mocerino R, et al. Infective endocarditis: Echocardiographic imaging and new imaging modalities. J Cardiovasc Echogr. 2019;29(4):149–55.CrossRefPubMedPubMedCentral
17.
Otto CM, Nishimura RA, Bonow RO, et al. ACC/AHA Guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;143(5):e35–e71.PubMed
18.
Falcone M, Tiseo G, Durante-Mangoni E, et al. Risk factors and outcomes of endocarditis due to Non-HACEK gram-negative bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort. Antimicrob Agents Chemother. 2018;62(4):e2208–17.CrossRefPubMedPubMedCentral
19.
Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ. Antibacterial Resistance Leadership Group. A primer on AmpC β‑Lactamases: Necessary knowledge for an increasingly multidrug-resistant world. Clin Infect Dis. 2019;69(8):1446–55.CrossRefPubMedPubMedCentral
20.
Ahmed T, Safdar A. Ethical Dilemma: Should continuous intravenous drug use affect appropriate management in prosthetic valve endocarditis? Cureus. 2020;12(6):e8458.PubMedPubMedCentral
Metadaten
Titel
A rare Serratia marcescens-associated acute endocarditis of a tricuspid valve in an intravenous drug user
A case report and literature review
verfasst von
Tibor Poruban
Mikulas Hunavy
Daniel Farkas
Stanislav Carnoky
Marta Jakubova
Publikationsdatum
31.05.2023
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 21-22/2023
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-023-02217-0

Weitere Artikel der Ausgabe 21-22/2023

Adult patients with tetanus in Slovenia 2006–2021

  • original article

MUW researcher of the month

  • MUW researcher of the month

Is the prognosis of traumatic critically ill pediatric patients predictable?

  • original article

Artificial Intelligence in der Medizin – wie man Segen erhält und Fluch verhindert

  • mitteilungen der gesellschaft der ärzte in wien

An alternative treatment option in older adults with knee osteoarthritis

  • original article

Correction to: Is the prognosis of traumatic critically ill pediatric patients predictable?

  • Correction